Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: Impact on intestinal and respiratory infections

International Journal of Food Microbiology

Volumn 141, Issue 1-2, 2010, Pages 82-89

  Salva, Susana ^a   Villena, Julio ^a   Alvarez, Susana ^a,b  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Cytokines; Immunomodulation; Intestinal infection; Lactobacillus rhamnosus; Respiratory infections

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; CYTOKINE; IMMUNOLOGIC FACTOR; CRL 1505; CRL 1506; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; CYTOKINE RELEASE; GOAT; IMMUNOMODULATION; INFECTION RESISTANCE; INNATE IMMUNITY; INTESTINE INFECTION; LACTOBACILLUS RHAMNOSUS; LEUKOCYTE COUNT; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MILK; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PERITONEUM MACROPHAGE; RESPIRATORY TRACT INFECTION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BLOOD; DISEASE MODEL; ENTEROPATHY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFECTION; ISOLATION AND PURIFICATION; LUNG; METABOLISM; MICROBIOLOGY; PHAGOCYTE; ANIMAL CELL; ANTIBODY SPECIFICITY; BACTERIAL STRAIN; DRUG EFFICACY; DRUG MECHANISM; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES; BLOOD; BRONCHOALVEOLAR LAVAGE; CYTOKINES; DISEASE MODELS, ANIMAL; GOATS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; INFECTION; INTESTINAL DISEASES; LACTOBACILLUS RHAMNOSUS; LUNG; MALE; MICE; MILK; PHAGOCYTES; PROBIOTICS; RESPIRATORY TRACT INFECTIONS; SALMONELLA TYPHIMURIUM; STREPTOCOCCUS PNEUMONIAE;

CAPRA HIRCUS; LACTOBACILLUS RHAMNOSUS; MUS; SALMONELLA TYPHIMURIUM; STREPTOCOCCUS PNEUMONIAE;

EID: 77953543692     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.03.013     Document Type: Article

References (38)

1. Agüero G., Villena J., Racedo S., Haro C., Alvarez S. Beneficial immunomodulatory activity of Lactobacillus casei in malnourished mice pneumonia: effect on inflammation and coagulation. Nutrition 2006, 22:810-819.
2. Bao S., Beagley K.W., France M.P., Shen J., Husband A.J. Interferon-gamma plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology 2000, 99:464-472.
3. Benbernou N., Nauciel C. Influence of mouse genotype and bacterial virulence in the generation of interferon-gamma producing cells during the early phase of Salmonella typhimurium infection. Immunology 1994, 83:245-249.
4. Borchers A.T., Selmi C., Meyers F.J., Keen C.L. Probiotics and immunity. J. Gastroenterol. 2009, 44:26-46.
5. Boyle R.J., Robins-Browne R.M., Tang M.L. Probiotic use in clinical practice: what are the risks?. American Journal of Clinical Nutrition 2006, 83:1256-1264.
6. Boyle E.C., Bishop J.L., Grassl G.A., Finlay B.B. Salmonella: from pathogenesis to therapeutics. J. Bacteriol. 2007, 189:1489-1495.
7. Chen Y., Nakane A., Minagawa T. Recombinant murine gamma interferon induces enhanced resistance to Listeria monocytogenes infection in neonatal mice. Infection and Immunity 1989, 57:2345-2349.
8. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 2002, 168:171-178.
9. Commane D., Hughes R., Shortt C., Rowland I. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutation Research 2005, 591:276-289.
10. Corthésy B., Boris S., Isler P., Grangette C., Mercenier A. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J. Infect. Dis. 2005, 192:1441-1449.
11. Cross M. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol. M. Microbiol. 2002, 34:245-253.
12. Delcenserie V., Martel D., Lamoureux M., Amiot J., Boutin Y., Roy Immunomodulatory effects of probiotics in the intestinal tract. Curr. Issues Mol. Biol. 2008, 10:37-54.
13. Dogi C.A., Maldonado-Galdeano C., Perdigón G. Gut immune stimulation by non pathogenic Gram (+) and Gram (-) bacteria. Comparison with a probiotic strain. Cytokine 2008, 41:223-231.
14. Foxwell R., Kyd J.M., Cripps A.W. Mucosal immunization against respiratory bacterial pathogens. Expert. Rev. Vaccines 2003, 2:551-560.
15. Gauffin Cano P., Agüero G., Perdigón G. Immunological effects of yogurt addition to a re-nutrition diet in a malnutrition experimental model. J. Dairy Res. 2002, 69:303-316.
16. Gueimonde M., Salminen S. New methods for selecting and evaluating probiotics. Dig. Liver. Dis. 2006, 38:242S-247S.
17. Haller D., Colbus H., Gänzle M.G., Scherenbacher P., Bode C., Hammes W.P. Metabolic and functional properties of lactic acid bacteria in the gastro-intestinal ecosystem: a comparative in vitro study between bacteria of intestinal and fermented food origin. Systematic and Applied Microbiology 2001, 24:218-226.
18. Jain S., Yadav H., Sinhá P.R. Stimulation of innate immunity by oral administration of dahi containing probiotic Lactobacillus casei in mice. J. Méd. Food 2008, 11:652-656.
19. Maassen C.B.M., van Holten-Neelen C., Balk F., Heijne den Bak-Glashouwer M.J., Leer R.J., Laman J.D., Boersma W.J.A., Claassen E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 2000, 18:2613-2623.
20. Maldonado-Galdeano C., de Moreno de LeBlanc A., Vinderola G., Bibas-Bonet M.E., Perdigon G. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vacc. Immunol. 2007, 14:485-492.
21. Medici M., Vinderola C.G., Weill R., Perdigon G. Effect of fermented milk containing probiotic bacteria in the prevention of an enteroinvasive Escherichia coli infection in mice. J. Dairy Res. 2005, 72:243-249.
22. Medina M., Izquierdo E., Ennahar S., Sanz Y. Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clinical and Experimental Immunology 2007, 150:531-538.
23. Perdigon G., Nader de Macias M.E., Alvarez S., Oliver G., de Ruiz Pesce, Holgado A. Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus. J. Dairy. Res. 1990, 57:255-264.
24. Perdigon G., Alvarez S., de Ruiz Pesce, Holgado A. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J. Dairy Res. 1991, 58:485-496.
25. Perdigon G., Agüero G., Alvarez S., Gaudiosos de Allori C., de Ruiz Pesce, Holgado A. Effect of viable Lactobacillus casei feeding on the immunity of the mucosae and intestinal microflora in mal-nourished mice. Milchwis 1995, 50:251-256.
26. Pineiro M., Stanton C. Probiotic bacteria: legislative framework-requirements to evidence basis. J. Nutr. 2007, 137:850-853.
27. Racedo S., Villena J., Medina M., Agüero G., Rodríguez V., Alvarez S. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. Microbes infect. 2006, 8:2359-2366.
28. Ramarathinam L., Shaban R.A., Niesel D.W., Klimpel G.R. Interferon gamma (IFN- gamma) production by gut associated lymphoid tissue and spleen following oral Salmonella typhimurium challenge. Microbial Pathogenesis 1991, 11:347-356.
29. Ravindran R., McSorley S.J. Tracking the dynamics of T-cell activation in response to Salmonella infection. Immunology 2005, 114:450-458.
30. Rudan I., Boschi-Pinto C., Biloglav Z., Mulhollandd K., Campbelle H. Epidemiology and etiology of childhood pneumonia. Bulletin of the World Health Organization 2008, 86:408-416.
31. Ruvinsky R., Gentile A., Regueira M., Corso A. Infecciones invasivas por Streptococcus pneumoniae: estudio epidemiológico e importancia del desarrollo de un sistema de vigilancia. Arch. Argent. Pediatr. 2002, 100:31-35.
32. Salva S., Villena J., Racedo S., Alvarez S., Agüero G. Lactobacillus casei addition to a repletion diet induced early normalization of cytokine profils during a pneumococcal infection in malnourished mice. Agric. Immunolog. 2008, 19:195-211.
33. Taranto M.P., Médici M., Perdigon G., de Ruiz Pesce, Holgado A., Valdez G.F. Evidence for cholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J. Dairy Sci. 1998, 81:2336-2340.
34. Villena J., Racedo S., Agüero G., Bru E., Medina M., Alvarez S. Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J. Nutr. 2005, 135:1462-1469.
35. Villena J., Medina M., Raya R., Alvarez S. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. Canadian Journal of Microbiology 2008, 54:845-853.
36. Vinderola G., Perdigon G., Duarte J., Farnworth E., Matar C. Effect of the oral administration of the exopolysaccharide produced by Lactobacillus Kefiranofaciens on the gut mucosal immunity. Cytokine 2006, 36:254-260.
37. Yamamoto N., Kawakami K., Kinjo Y., Miyagi K., Kinjo T., Uezu K., Nakasone C., Nakamatsu M., Saito A. Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-gamma. Microbes Infect. 2004, 6:1241-1249.
38. Zeuthen L.H., Christensen H.R., Frokiaer H. Lactic acid bacteria inducing weak interleukin-12 and tumor necrosis factor a response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with Gram-negative bacteria. Clin. Vaccine Immunol. 2006, 13:365-375.